138 related articles for article (PubMed ID: 34716280)
1. Selection of eligible participants for screening for lung cancer using primary care data.
O'Dowd EL; Ten Haaf K; Kaur J; Duffy SW; Hamilton W; Hubbard RB; Field JK; Callister ME; Janes SM; de Koning HJ; Rawlinson J; Baldwin DR
Thorax; 2022 Sep; 77(9):882-890. PubMed ID: 34716280
[TBL] [Abstract][Full Text] [Related]
2. Analysis of lung cancer risk model (PLCO
Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
[TBL] [Abstract][Full Text] [Related]
3. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
4. Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
Bartlett EC; Kemp SV; Ridge CA; Desai SR; Mirsadraee S; Morjaria JB; Shah PL; Popat S; Nicholson AG; Rice AJ; Jordan S; Begum S; Mani A; Derbyshire J; Morris K; Chen M; Peacock C; Addis J; Martins M; Kaye SB; Padley SPG; Devaraj A;
Lung Cancer; 2020 Oct; 148():12-19. PubMed ID: 32771715
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the accuracy of the PLCO
Jantzen R; Ezer N; Camilleri-Broët S; Tammemägi MC; Broët P
CMAJ Open; 2023; 11(2):E314-E322. PubMed ID: 37041013
[TBL] [Abstract][Full Text] [Related]
6. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
7. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
[TBL] [Abstract][Full Text] [Related]
8. When to reinvite initially ineligible populations for targeted lung cancer screening?
Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
[TBL] [Abstract][Full Text] [Related]
9. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
10. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
[TBL] [Abstract][Full Text] [Related]
11. Stratification and management of patients ineligible for lung cancer screening.
Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
[TBL] [Abstract][Full Text] [Related]
12. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
14. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
15. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
[TBL] [Abstract][Full Text] [Related]
16. Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation.
Field JK; Vulkan D; Davies MPA; Duffy SW; Gabe R
Thorax; 2021 Feb; 76(2):161-168. PubMed ID: 33082166
[TBL] [Abstract][Full Text] [Related]
17. Selection of individuals for lung cancer screening based on risk prediction model performance and economic factors - The Ontario experience.
Tammemägi MC; Darling GE; Schmidt H; Llovet D; Buchanan DN; Leung Y; Miller B; Rabeneck L
Lung Cancer; 2021 Jun; 156():31-40. PubMed ID: 33887677
[TBL] [Abstract][Full Text] [Related]
18. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
19. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
Hüsing A; Kaaks R
Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
